TransMedics Group Inc. logo

TransMedics Group Inc.

TMDX | NASDAQ
Chart Builder DCF Calculator
$88.63
+$1.34 (+1.54%)
Sep 22, 2026, 2:21 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
488.37M 336.65M 394.81M 201.18M 25.58M 24.58M
Short-Term Investments
n/a n/a n/a n/a 66.87M 101.06M
Long-Term Investments
n/a n/a n/a 500K 500K n/a
Other Long-Term Assets
739K 708K 562K n/a n/a 506K
Receivables
84.28M 97.72M 63.58M 27.61M 5.93M 6.86M
Inventory
48.88M 46.55M 44.24M 20.61M 14.86M 11.93M
Other Current Assets
16.25M 16.29M 8.03M 2.9M 5.46M 2.33M
Total Current Assets
637.78M 497.22M 510.65M 252.29M 118.71M 146.77M
Property-Plant & Equipment
332.81M 292.45M 180.49M 24.35M 15.69M 4.75M
Goodwill & Intangibles
13.5M 13.7M 14.34M n/a n/a n/a
Total Long-Term Assets
430.59M 306.86M 195.39M 24.85M 16.19M 5.26M
Total Assets
1.07B 804.08M 706.05M 277.15M 134.89M 152.03M
Account Payables
10.35M 10.29M 12.72M 3.34M 6.65M 1.21M
Deferred Revenue
2.91M 1.74M 1.96M 241K 250K 263K
Short-Term Debt
13.31M 2.73M n/a n/a n/a n/a
Other Current Liabilities
62.74M 45.15M 17.92M 8.82M 11.16M 6.38M
Total Current Liabilities
89.31M 59.91M 54.93M 23.66M 23.24M 11.88M
Long-Term Debt
456.38M 509.31M 506.2M 58.7M 35.2M 34.66M
Other Long-Term Liabilities
49.59M n/a n/a n/a n/a 1.6M
Total Long-Term Liabilities
505.97M 515.56M 513.91M 66.11M 43.8M 36.26M
Total Liabilities
595.27M 575.47M 568.85M 89.77M 67.04M 48.14M
Total Debt
469.69M 518.29M 515.95M 67.56M 43.8M 34.66M
Book Value
473.1M 228.6M 137.2M 187.38M 67.85M 103.89M
Book Value Per Share
11.67 6.49 4.22 6.34 2.46 4.21
Common Stock
750.93M 697.21M 641.11M 666.28M 510.49M 502.22M
Retained Earnings
-277.95M -468.24M -503.71M -478.68M -442.45M -398.23M
Comprehensive Income
124K -364K -199K -225K -188K -95K
Shareholders Equity
473.1M 228.6M 137.2M 187.38M 67.85M 103.89M
Total Investments
n/a n/a n/a 500K 67.37M 101.06M

© 2026 bestshares.com. All rights reserved.